Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Originally on
Cheeky Pint (Stripe) · hosted by John & Patrick Collison (Stripe)
The guest
Dave Ricks
CEO, Eli Lilly
CEO of Eli Lilly on the GLP-1 origin, the compounder threat and the business of modern pharma.
In this episode
- The GLP-1 origin story
- Compounding pharmacies and IP
- LillyDirect and drug pricing
- $14BN R&D and the retatrutide threat
Listen & watch
Keep listening